Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation

Completed

Conditions studied: Barrett's Esophagus

In brief

The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.

Key facts

Study ID

NCT01568723

Run by

Mayo Clinic

People needed

125

Starts

2012-01-01

Expected to finish

2018-08-16

Last updated by the study team

2021-12-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Barrett's esophagus with high grade dysplasia or intramucosal (early) adenocarcinoma.
• BE length ≥ 2 cm and ≤ 8 cm.
• Able to return every 3 months for one year after ablation

You may not qualify if…

• Patients who are unable to be compliant with follow-up endoscopies
• patients who cannot tolerate Proton Pump inhibitors
• pre-existing esophageal strictures
• pregnant or nursing women

Where it is running

• Columbia University — New York, New York, United States
• University of Pennsylvania Perelman School of Medicine — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.